New treatment study for moderate to severe ulcerative colitis
Part of Digestive system clinical trials.
This study tests several new treatments to see if they are safe and helpful for people with moderate to severe ulcerative colitis. If you have not responded well to standard treatments, this might be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with ulcerative colitis for at least 3 months.
- Your disease must be moderate to severe, with active inflammation seen in a colonoscopy.
- You must have at least 15 cm of active disease beyond the rectum.
- You must have tried standard treatments like 5-ASA, steroids, or thiopurines without enough success.
- You cannot have Crohn's disease, IBD-unclassified, or certain other bowel conditions.
- You must not have had surgery to remove your colon or have a stoma or pouch.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called aletekitug for people with moderate to severe ulcerative colitis (UC). It aims to see if it's safe and if it can help control symptoms.
This study tests a new drug called JNJ-78934804 to treat ulcerative colitis (inflammation of the colon and rectum) that is moderate to severe and hasn't responded well to standard treatments. The goal is to see if this drug can reduce inflammation and improve symptoms.
This study tests an investigational drug for people with active mild-to-moderate ulcerative colitis. It aims to see if the drug can improve symptoms without needing advanced treatments like biologics.
This study tests a new combination of two drugs to see if they are safe and help reduce ulcerative colitis symptoms. It is for people who have not gotten enough relief from other treatments.
This trial tests an investigational drug called MK-8690 for people with moderate to severe ulcerative colitis (UC) who haven't responded well to other treatments or can't tolerate them. The study aims to see if the drug can help control UC symptoms safely.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
Hear when a new Colitis, Ulcerative trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.